Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-04-03
1993-10-19
Brust, Joseph Paul
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514374, 548203, 548204, 548205, 548235, 548236, A61K 3154, A61K 31535, C07D41704, C07D41304
Patent
active
052545768
ABSTRACT:
A novel series of oxazole derivatives having enhanced water solubility bioavailability and metabolic stability is disclosed in the Formula I ##STR1## X is ##STR2## R is CH.sub.2 R.sup.2, H; R.sup.1 is Ph or Th;
REFERENCES:
patent: 4460598 (1984-07-01), Lauutenschlager et al.
Lautenschlager, et al., Drugs of the Future, 11, 26 (1986).
Moncoda, et al., Nature, 263, 663 (1976).
Nickolson, et al., Med. Res. Rev., 5, 1 (1985).
Seiler, et al., J. Pharmacol. Exp. Ther., 255: 1021 (1990).
T. Shioiri, Y. Hamada, Heterocycles, 27: 1035: (1988).
Waserman, et al., Chem. Rev., 86: 845 (1986).
G. D. Hartman, L. M. Weinstock, Org. Syn., VI, 620 (1976).
J. L. Kraus, Synth. Comm., 16: 827 (1986).
J. F. W. McOmie, M. L. Watts, Chem. Ind., 1658 (1963).
Negishi et al., J. Org. Chem., 42: 1821 (1977).
Wasserman, et al., Tetrahedron Lett., 22: 1737 (1981).
R. F. Abdulla, R. S. Brinkmeyer, Tetrahedron, 35: 1675 (1979).
A. P. Kozikowski, A. J. Ames, J. Org. Chem., 45: 2548 (1980).
Moriya, et al., J. Med. Chem., 29: 333 (1986).
D. Hoppe, Angew. Chem., Int. Ed., 13: 789 (1974).
J. Frump, Chem. Rev., 71: 483 (1971).
H. Eckert, B. Forster, Angew. Chem. Int. Ed., 26: 894 (1987).
Suzuki, et al., J. Org. Chem., 38: 3571-3575 (1973).
H. Reimlinger, Chemistry and Industry, 1082-1083 (1970).
Davidson, et al., J. Org. Chem., 2: 319 (1937).
I. Yamawaki, K. Ogawa, Chem. Pharm. Bull., 36: 3142 (1988).
Meanwell, et al., J. Of Med. Chem., 35: 389-397 (1992).
Merritt, et al., Br. J. Pharmacol., 102: 251-259 (1991).
Merritt, et al., Br. J. Pharmacol., 102: 260-266 (1991).
Martin Scott W.
Meanwell Nicholas A.
Romine Jeffrey L.
Bristol--Myers Squibb Company
Brust Joseph Paul
Gabilen MarySusan H.
Kaye Michelle A.
LandOfFree
Diphenyl-heterocyclic-oxazole as platelet aggregation inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diphenyl-heterocyclic-oxazole as platelet aggregation inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diphenyl-heterocyclic-oxazole as platelet aggregation inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1352049